To interrogate the clinical significance of LRIG3 in gliomas, tumor samples from 65 patients (20 cases of grade II, 17 cases of grade III, and 28 cases of grade IV) were collected for LRIG3 IHC staining to analyze the correlation between LRIG3 protein expression levels and overall survival. This evidence concerns the gene LRIG3 and central nervous system cancer.